Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Plasma markers of COVID-19 severity: a pilot study

Fig. 2

Thrombosis marker ADAMTS13 in COVID-19 patients with different disease severities: Plasma levels of ADAMTS13 were measured in 10 severely and 10 moderately ill COVID-19 patients as well as in 10 healthy controls. Values are given as median (IQR). P-values were calculated by Kruskal–Wallis test and Dunn’s multiple comparison test. A p-value below 0.05 was considered a significant

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us